Research Oversight Committees
The Leukemia & Lymphoma Society's (LLS's) Research Oversight Committees are comprised of leading experts in their fields. Committee members are volunteers who give their time and talent to LLS and receive no compensation for their generous support.
Medical & Scientific Affairs Committee
Advises the Board of Directors on a range of issues, including recommending funding for research grant awards and periodically reviewing LLS’s medical affairs
Jonathan D. Licht, MD (Chair)
UF Gainesville
Omar Abdel-Wahab, MD
Memorial Sloan Kettering Cancer Center
Stephen Ansell, MD, PhD
Mayo Clinic, Rochester
Leif Bergsagel, MD
Mayo Clinic, Arizona
Ravi Bhatia, MD
The University of Alabama at Birmingham
Catherine Bollard, MD
Georgetown University
Lori Brown, PhD, MPH
FDA, Investigations Branch (formerly)
Renzo Canetta, MD +
Bristol-Myers Squibb (formerly)
Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center
Christopher Flowers, MD
The University of Texas MD Anderson Cancer Center
Janice Gabrilove, MD +
Mount Sinai
Irene Ghobrial, MD
Dana-Farber Cancer Institute
Larry Kwak, MD, PhD
City of Hope
Ruben Mesa, MD +
UT Health San Antonio
TAP Committee & Advisory Council
Provides oversight and guidance on LLS’s Therapy Acceleration Program (TAP), a strategic initiative through which LLS partners directly with biotechnology companies to help accelerate the development of promising therapies
Committee
Casey Cunningham, MD (Chair) +
Santé Ventures
Ari Melnick, MD +
Weill Cornell Medicine
Jim Reddoch, PhD +
Royalty Pharma
Robert Rosen, JD +
Grewhawke Capital Advisors
Lilian Stern, JD +
Precision AQ
Advisory Council
Stephen Ansell, MD, PhD
Mayo Clinic Rochester
Philippe Armand, MD, PhD
Dana-Farber Cancer Institute
Asher Chanan-Khan, MD
Mayo Clinic, Jacksonville
Madhav Dhodapkar, MBBS
Emory University
Courtney DiNardo, MD
MD Anderson Cancer Center
Giulio Draetta, MD, PhD
MD Anderson Cancer Center
Ian Flinn, MD, PhD
Sarah Cannon Research Institute
Christopher Flowers, MD
MD Anderson Cancer Center
Patrick Fortune, PhD, MBA
Partners Heathcare Systems
Mitul Gandhi, MD
Virginia Cancer Specialists
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
Tapan Kadia, MD
MD Anderson Cancer Center
Ross Levine, MD
Memorial Sloan Kettering Cancer Center
Ronald Levy, MD
Stanford University School of Medicine
Frederick Locke, MD
Moffitt Cancer Center
Tak Mak, PhD
Princess Margaret Cancer Center
Ruben Mesa, MD +
UT Health San Antonio
Vern Norviel, JD
Wilson Sonsini Goodrich & Rosati
Susan O’Brien, MD
University of California, Irvine
Daniel Pollyea, MD
University of Colorado
Steven Rosen, MD
City of Hope
Michael Savona, MD
Vanderbilt University
Aaron Schimmer, MD, PhD
Princess Margaret Cancer Center
Jeff Sharman, MD
US Oncology
Robert Spiegel, MD
Spiegel Consulting LLC
Daniel Starcyznowski, PhD
Cincinnati Children’s Hospital
Keith Stewart, MD
Princess Margaret Cancer Center
Sarah Tasian, MD
Children’s Hospital of Philadelphia
Amit Verma, MD
Albert Einstein College of Medicine
+ National Board Member